ANAPLASTIC OLIGOASTROCYTOMA
Clinical trials for ANAPLASTIC OLIGOASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC OLIGOASTROCYTOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC OLIGOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on recurrent brain tumors shows promise in early trial
Disease control Recruiting nowThis phase 2 trial tests a new way to deliver the cancer drug cetuximab directly into the brain's arteries, along with mannitol to open the blood-brain barrier, plus targeted radiation. It is for adults with recurrent glioblastoma or other aggressive brain tumors that have high l…
Matched conditions: ANAPLASTIC OLIGOASTROCYTOMA
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New combo therapy targets aggressive brain tumors in phase 2 trial
Disease control Recruiting nowThis study tests a more intense treatment for a fast-growing type of brain cancer called IDH wildtype glioma. It combines higher doses of radiation with the chemotherapy drug temozolomide to try to stop the tumor from growing longer. The trial will enroll 40 adults with this spec…
Matched conditions: ANAPLASTIC OLIGOASTROCYTOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC